Human apolipoprotein A-I natural variants: molecular mechanisms underlying amyloidogenic propensity

cic.isFulltexttruees
cic.isPeerReviewedtruees
cic.lugarDesarrolloUniversidad Nacional de La Plata es
cic.versioninfo:eu-repo/semantics/publishedVersiones
dc.date.accessioned2014-12-17T09:24:26Z
dc.date.available2014-12-17T09:24:26Z
dc.identifier.urihttps://digital.cic.gba.gob.ar/handle/11746/200
dc.titleHuman apolipoprotein A-I natural variants: molecular mechanisms underlying amyloidogenic propensityen
dc.typeArtículoes
dcterms.abstractHuman apolipoprotein A-I (apoA-I)-derived amyloidosis can present with either wild-type (Wt) protein deposits in atherosclerotic plaques or as a hereditary form in which apoA-I variants deposit causing multiple organ failure. More than 15 single amino acid replacement amyloidogenic apoA-I variants have been described, but the molecular mechanisms involved in amyloid-associated pathology remain largely unknown. Here, we have investigated by fluorescence and biochemical approaches the stabilities and propensities to aggregate of two disease-associated apoA-I variants, apoA-IGly26Arg, associated with polyneuropathy and kidney dysfunction, and apoA-ILys107-0, implicated in amyloidosis in severe atherosclerosis. Results showed that both variants share common structural properties including decreased stability compared to Wt apoA-I and a more flexible structure that gives rise to formation of partially folded states. Interestingly, however, distinct features appear to determine their pathogenic mechanisms. ApoA-ILys107-0 has an increased propensity to aggregate at physiological pH and in a pro-inflammatory microenvironment than Wt apoA-I, whereas apoA-IGly26Arg elicited macrophage activation, thus stimulating local chronic inflammation. Our results strongly suggest that some natural mutations in apoA-I variants elicit protein tendency to aggregate, but in addition the specific interaction of different variants with macrophages may contribute to cellular stress and toxicity in hereditary amyloidosis.en
dcterms.creator.authorRamella, Nahueles
dcterms.creator.authorSchinella, Guillermo Raúles
dcterms.creator.authorFerreira, Sergio T.es
dcterms.creator.authorPrieto, Eduardo Danieles
dcterms.creator.authorVela, María Elenaes
dcterms.creator.authorRíos, José Luises
dcterms.creator.authorTricerri, Alejandraes
dcterms.creator.authorRimoldi, Omar J.es
dcterms.extent11 p.es
dcterms.identifier.otherdoi:10.1371/journal.pone.0043755es
dcterms.identifier.urlDocumento Completoes
dcterms.isPartOf.issuevol. 7, no. 8es
dcterms.isPartOf.seriesPlos Onees
dcterms.issued2012
dcterms.languageIngléses
dcterms.licenseAttribution 4.0 International (BY 4.0)es
dcterms.relationInforme Científico de Investigador: Vela, María Elena (2012-2013)es
dcterms.subjectamyloidosisen
dcterms.subjectfluorescenseen
dcterms.subjectinflammationen
dcterms.subjectmacrophagesen
dcterms.subjectneutrophilsen
dcterms.subjectoligomersen
dcterms.subjectpolymyxinsen
dcterms.subject.materiaCiencias Químicases
Archivos
Paquete original
Mostrando1 - 1 de 1
Imagen en miniatura
Nombre:
Vela_Human Apolipoprotein A-I Natural Variants.pdf
Tamaño:
1.08 MB
Formato:
Adobe Portable Document Format
Descripción:
Documento completo